Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645898.RAXJMbvc6mTlsa7N3NULsTGhxOrlRubYCLeNrqRkhpHDM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645898.RAXJMbvc6mTlsa7N3NULsTGhxOrlRubYCLeNrqRkhpHDM130_assertion type Assertion NP645898.RAXJMbvc6mTlsa7N3NULsTGhxOrlRubYCLeNrqRkhpHDM130_head.
- NP645898.RAXJMbvc6mTlsa7N3NULsTGhxOrlRubYCLeNrqRkhpHDM130_assertion description "[Prompted by this finding and because RAS/RAF/MEK mutations are known mediators of acquired resistance in other solid tumors (colon cancers, gastrointestinal stromal tumors, and melanomas) responsive to targeted therapies, we analyzed the frequency of secondary KRAS/NRAS/BRAF/MEK1 gene mutations in the largest collection to date of lung cancers with acquired resistance to EGFR TKIs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645898.RAXJMbvc6mTlsa7N3NULsTGhxOrlRubYCLeNrqRkhpHDM130_provenance.
- NP645898.RAXJMbvc6mTlsa7N3NULsTGhxOrlRubYCLeNrqRkhpHDM130_assertion evidence source_evidence_literature NP645898.RAXJMbvc6mTlsa7N3NULsTGhxOrlRubYCLeNrqRkhpHDM130_provenance.
- NP645898.RAXJMbvc6mTlsa7N3NULsTGhxOrlRubYCLeNrqRkhpHDM130_assertion SIO_000772 22773810 NP645898.RAXJMbvc6mTlsa7N3NULsTGhxOrlRubYCLeNrqRkhpHDM130_provenance.
- NP645898.RAXJMbvc6mTlsa7N3NULsTGhxOrlRubYCLeNrqRkhpHDM130_assertion wasDerivedFrom befree-20150227 NP645898.RAXJMbvc6mTlsa7N3NULsTGhxOrlRubYCLeNrqRkhpHDM130_provenance.
- NP645898.RAXJMbvc6mTlsa7N3NULsTGhxOrlRubYCLeNrqRkhpHDM130_assertion wasGeneratedBy ECO_0000203 NP645898.RAXJMbvc6mTlsa7N3NULsTGhxOrlRubYCLeNrqRkhpHDM130_provenance.